Autologous platelet concentrates for facial rejuvenation.

Journal of applied oral science : revista FOB Pub Date : 2022-09-05 eCollection Date: 2022-01-01 DOI:10.1590/1678-7757-2022-0020
Marília Afonso Rabelo Buzalaf, Flávia Mauad Levy
{"title":"Autologous platelet concentrates for facial rejuvenation.","authors":"Marília Afonso Rabelo Buzalaf,&nbsp;Flávia Mauad Levy","doi":"10.1590/1678-7757-2022-0020","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Autologous platelet concentrates (APCs) are promising therapeutic agents in facial rejuvenation since they are a great source of cytokines, growth factors and other biologically active substances. Obtained from the patient's blood, they have the advantages of reducing immunological reactions, making the procedure safer, well tolerated, with minimal adverse effects and lower cost. Currently, they are used for facial rejuvenation both in combination with microneedling and in mesotherapy techniques, as well as to treat facial acne scars, melasma and wounds after laser ablative treatments. This review summarizes current knowledge on the use of APCs, ranging from basic concepts related to their composition and mechanisms of action to up-to-date information on their clinical efficacy.</p><p><strong>Methodology: </strong>MEDLINE (PubMed) was searched from inception through 2021 for English language publications on APCs for facial rejuvenation.</p><p><strong>Results: </strong>A total of 100 files were found. Based on the available literature, APCs for skin rejuvenation are safe and well tolerated. The most studied product is the first-generation material, platelet-rich plasma (PRP).</p><p><strong>Conclusions: </strong>The results are in general favorable, but the quality of the studies is low. The second and third generation products, platelet-rich fibrin (PRF) and injectable platelet-rich fibrin (i-PRF), respectively, are easier to be obtained and, at least in vitro , seem to induce greater collagen production than PRP, especially under lower relative centrifugation forces, but to date only a few clinical trials evaluating these products exist. More high-quality trials with appropriate follow-up are necessary to provide adequate evidence that may help to improve the treatment regimens with APCs. Many aspects should be considered when designing clinical trials to evaluate APCs, such as the patients' characteristics that best predict a favorable response, the optimal number of sessions and the interval between them, the characteristics of the studies and the development of better instruments to evaluate skin aging.</p>","PeriodicalId":321675,"journal":{"name":"Journal of applied oral science : revista FOB","volume":" ","pages":"e20220020"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444188/pdf/","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of applied oral science : revista FOB","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1590/1678-7757-2022-0020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

Background: Autologous platelet concentrates (APCs) are promising therapeutic agents in facial rejuvenation since they are a great source of cytokines, growth factors and other biologically active substances. Obtained from the patient's blood, they have the advantages of reducing immunological reactions, making the procedure safer, well tolerated, with minimal adverse effects and lower cost. Currently, they are used for facial rejuvenation both in combination with microneedling and in mesotherapy techniques, as well as to treat facial acne scars, melasma and wounds after laser ablative treatments. This review summarizes current knowledge on the use of APCs, ranging from basic concepts related to their composition and mechanisms of action to up-to-date information on their clinical efficacy.

Methodology: MEDLINE (PubMed) was searched from inception through 2021 for English language publications on APCs for facial rejuvenation.

Results: A total of 100 files were found. Based on the available literature, APCs for skin rejuvenation are safe and well tolerated. The most studied product is the first-generation material, platelet-rich plasma (PRP).

Conclusions: The results are in general favorable, but the quality of the studies is low. The second and third generation products, platelet-rich fibrin (PRF) and injectable platelet-rich fibrin (i-PRF), respectively, are easier to be obtained and, at least in vitro , seem to induce greater collagen production than PRP, especially under lower relative centrifugation forces, but to date only a few clinical trials evaluating these products exist. More high-quality trials with appropriate follow-up are necessary to provide adequate evidence that may help to improve the treatment regimens with APCs. Many aspects should be considered when designing clinical trials to evaluate APCs, such as the patients' characteristics that best predict a favorable response, the optimal number of sessions and the interval between them, the characteristics of the studies and the development of better instruments to evaluate skin aging.

Abstract Image

Abstract Image

Abstract Image

自体血小板浓缩液用于面部年轻化。
背景:自体血小板浓缩物(APCs)富含细胞因子、生长因子和其他生物活性物质,是一种很有前景的面部年轻化治疗药物。从患者的血液中获得,它们具有减少免疫反应的优点,使手术更安全,耐受性好,副作用最小,成本更低。目前,它们被用于面部年轻化,既可以与微针结合使用,也可以用于治疗激光消融治疗后的面部痤疮疤痕、黄褐斑和伤口。本文综述了目前关于APCs使用的知识,从其组成和作用机制的基本概念到其临床疗效的最新信息。方法:检索MEDLINE (PubMed)从成立到2021年关于面部年轻化APCs的英文出版物。结果:共找到100个文件。根据现有文献,APCs用于皮肤再生是安全且耐受性良好的。研究最多的产品是第一代材料,富血小板血浆(PRP)。结论:研究结果总体上是有利的,但研究质量较低。第二代和第三代产品,富血小板纤维蛋白(PRF)和可注射的富血小板纤维蛋白(i-PRF),分别更容易获得,至少在体外,似乎比PRP诱导更大的胶原生成,特别是在较低的相对离心力下,但迄今为止只有少数临床试验评估这些产品存在。有必要进行更多高质量的试验,并进行适当的随访,以提供足够的证据,帮助改进APCs的治疗方案。在设计评估apc的临床试验时,应考虑许多方面,例如最能预测良好反应的患者特征、最佳疗程数量和疗程之间的间隔、研究的特征以及更好的皮肤老化评估仪器的开发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信